Laing RB et al. |
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. |
1996 |
Int J STD AIDS |
pmid:8876356
|
Tansey MJ and Moe JB |
Severe neutropenia and prophylactic doses of rifabutin. |
1996 |
Lancet |
pmid:8950911
|
Sefton AM et al. |
Azithromycin in the treatment of periodontal disease. Effect on microbial flora. |
1996 |
J. Clin. Periodontol. |
pmid:8951627
|
Griffith DE et al. |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. |
1996 |
Clin. Infect. Dis. |
pmid:8953085
|
|
Prophylactic antibiotic receives speedy FDA approval to reduce MAC disease in advanced HIV. |
1996 |
AIDS Patient Care STDS |
pmid:11361569
|
|
Azithromycin and OIs. |
1996 |
AIDS Patient Care STDS |
pmid:11361699
|
Bertoni G et al. |
Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. |
1996 |
Am. J. Gastroenterol. |
pmid:8607489
|
Di Mario F et al. |
Azithromycin for the cure of Helicobacter pylori infection. |
1996 |
Am. J. Gastroenterol. |
pmid:8607490
|
Dupont C et al. |
Microbiological findings about pulmonary cryptosporidiosis in two AIDS patients. |
1996 |
J. Clin. Microbiol. |
pmid:8748314
|
Wildfeuer A et al. |
Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8787883
|
Okamoto T and Sekiguchi T |
[Clinical studies on azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8986557
|
Toyonaga Y et al. |
[Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients]. |
1996 |
Jpn J Antibiot |
pmid:8988410
|
Okumura A and Kuno K |
[Pharmacokinetic and clinical evaluation of azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8988411
|
Kobayashi Y et al. |
[Clinical study of a macrolide antibiotic, azithromycin, in pediatric patients]. |
1996 |
Jpn J Antibiot |
pmid:8988412
|
O'Doherty B |
Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8922571
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
Preac Mursic V et al. |
Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis. |
1996 Jan-Feb |
Infection |
pmid:8852456
|
Baradaran-Dilmaghani R and Stanek G |
In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics. |
1996 Jan-Feb |
Infection |
pmid:8852472
|
Strle F et al. |
Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. |
1996 Jan-Feb |
Infection |
pmid:8852473
|
Fontán PA et al. |
Haemophilus influenzae type b exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes. |
1996 Jan-Feb |
Chemotherapy |
pmid:8751269
|
Ehret JM et al. |
A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin. |
1996 Jul-Aug |
Sex Transm Dis |
pmid:8836018
|
Lane G |
Increased hypoprothrombinemic effect of warfarin possibly induced by azithromycin. |
1996 Jul-Aug |
Ann Pharmacother |
pmid:8826581
|
Diculencu D et al. |
[The postantibiotic effect of azithromycin on respiratory pathogens]. |
1996 Jul-Dec |
Rev Med Chir Soc Med Nat Iasi |
pmid:9455450
|
Carlin EM and Barton SE |
Azithromycin as the first-line treatment of non-gonococcal urethritis (NGU): a study of follow-up rates, contact attendance and patients' treatment preference. |
1996 May-Jun |
Int J STD AIDS |
pmid:8799780
|
Shanks GD et al. |
Azithromycin prophylaxis prevents epidemic dysentery. |
1996 May-Jun |
Trans. R. Soc. Trop. Med. Hyg. |
pmid:8758091
|
Adam D et al. |
Re: A. Bauernfeind et al.: Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens (Infection 23 [1995] 316-321) |
1996 May-Jun |
Infection |
pmid:8811372
|
Vranes J |
Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains. |
1996 May-Jun |
Chemotherapy |
pmid:8983884
|
Ichimiya T et al. |
The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. |
1996 May-Jun |
Chemotherapy |
pmid:8983885
|
Galova K et al. |
Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. |
1996 May-Jun |
Chemotherapy |
pmid:8983893
|
Burke SM |
Azithromycin: only once a day. |
1996 May-Jun |
MCN Am J Matern Child Nurs |
pmid:8857402
|
Ripa S et al. |
A linear model for the pharmacokinetics of azithromycin in healthy volunteers. |
1996 Nov-Dec |
Chemotherapy |
pmid:8957574
|
D'Amico R |
ICAAC update on opportunistic infections. |
1996 Nov-Dec |
Posit Aware |
pmid:11363974
|
Wendel TD |
1-day azithromycin was as effective as 7-day doxycycline for nongonococcal urethritis syndrome in men. |
1996 Nov-Dec |
ACP J. Club |
pmid:8912627
|
Peeling RW and Brunham RC |
Chlamydiae as pathogens: new species and new issues. |
1996 Oct-Dec |
Emerging Infect. Dis. |
pmid:8969247
|
Biebuyck XA |
Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group. |
1996 Sep-Oct |
J. Int. Med. Res. |
pmid:8895044
|
New DL et al. |
Vertically transmitted babesiosis. |
1997 |
J. Pediatr. |
pmid:9255211
|
Pacifico L and Chiesa C |
Efficacy of three-day azithromycin vs. ten-day penicillin V in the treatment of streptococcal pharyngitis. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9154566
|
Fernandez-Obregon AC |
Azithromycin for the treatment of acne. |
1997 |
Int. J. Dermatol. |
pmid:9159021
|
Nightingale CH |
Pharmacokinetics and pharmacodynamics of newer macrolides. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109156
|
Block SL |
Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109158
|
Tarlow MJ et al. |
Future indications for macrolides. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109159
|
Dawson CR et al. |
A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. |
1997 |
Clin. Infect. Dis. |
pmid:9114186
|
Caselli M et al. |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. |
1997 |
Eur J Gastroenterol Hepatol |
pmid:9031898
|
Arévalo Morles C et al. |
Donovanosis: treatment with azithromycin. |
1997 |
Int J STD AIDS |
pmid:9043983
|
Hoepelman IM et al. |
A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome. |
1997 |
Int. J. Antimicrob. Agents |
pmid:9552709
|
Gupta S et al. |
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. |
1997 |
Circulation |
pmid:9244203
|
Vazifeh D et al. |
Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9333032
|
Nilius AM et al. |
Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH. |
1997 |
J. Clin. Microbiol. |
pmid:9163435
|
Rajyaguru JM and Muszynski MJ |
Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds. |
1997 |
J. Antimicrob. Chemother. |
pmid:9338485
|
Odenholt I et al. |
Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371360
|